Review
doi: 10.1007/BF02765743.
Treatment of polycystic ovary patients undergoing IVF
Affiliations
- PMID: 9013302
- PMCID: PMC3454708
- DOI: 10.1007/BF02765743
Item in Clipboard
Review
Treatment of polycystic ovary patients undergoing IVF
J Assist Reprod Genet.
1997 Jan.
Abstract
We believe that PCO patients can achieve good results in IVF cycles, provided that stimulation protocols appropriate to their hormonal profiles are used.
The dose of gonadotropin used seems to be more important than the type of gonadotropin. If there is a risk of ovarian hyperstimulation, it is useful to employ one of the strategies recommended to prevent development of genuine OHS, which may endanger the patient’s health.
Similar articles
-
The treatment of patients with polycystic ovaries undergoing IVF.J Assist Reprod Genet. 1997 Jan;14(1):12-4. doi: 10.1007/BF02765744. J Assist Reprod Genet. 1997. PMID: 9013303 Free PMC article. Review. No abstract available.
-
Clinical utility of adjuvant growth hormone in the treatment of patients with polycystic ovaries undergoing in vitro fertilization.J Assist Reprod Genet. 1997 Jan;14(1):4-7. doi: 10.1007/BF02765741. J Assist Reprod Genet. 1997. PMID: 9013300 Free PMC article. Review. No abstract available.
-
In vitro fertilization treatment in patients with polycystic ovaries.J Assist Reprod Genet. 1997 Jan;14(1):7-10. doi: 10.1007/BF02765742. J Assist Reprod Genet. 1997. PMID: 9013301 Free PMC article. Review. No abstract available.
-
The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.J Assist Reprod Genet. 1997 Jan;14(1):1-4. doi: 10.1007/BF02765740. J Assist Reprod Genet. 1997. PMID: 9013299 Free PMC article. Review.
-
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.Fertil Steril. 2008 Jan;89(1):84-91. doi: 10.1016/j.fertnstert.2007.02.002. Epub 2007 Apr 26. Fertil Steril. 2008. PMID: 17462639 Clinical Trial.
References
-
- Asch RH, Ivery G, Goldsman M, Frederick JL, Stone SC, Balmaceda JP. The use of intravenous albumin in patients at high risk for severe OHSS. Hum Reprod. 1993;8:1015–1020. - PubMed
-
- Barri PN: Respuesta Anomala a la Estimulacion de la Maduracion Folicular en FIV. Doctoral thesis, Universidad de Barcelona, Barcelona
-
- Balasch J, Jove Y, Moreno V, Civico S, Puerto B, Vanrell JA. The comparison of two GnRHa in an IVF program. Fertil Steril. 1992;58(5):991–994. - PubMed
-
- Balen AH, Tan SL, Jacobs HS. Hypersecretion of luteinizing hormone: A significant cause of infertility and miscarriage. Br J Obstet Gynaecol. 1993;100:1082–1089. - PubMed
-
- Berg C, Hamberger L. Cumulative birth rates by IVF including cryopreservation of all embryos. Assist Reprod Rev. 1995;5:195–200. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical